SEC Form 4 · accession 0002147380-26-000006
Bionano Genomics, Inc. · BNGO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Alex Reid Hastie
Officer — Chief Scientific Officer
Period of report
Aug 3, 2026
Accepted (ET)
Aug 5, 2026 · 5:26 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001411690
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F2,F1 | $1.12 | Aug 3, 2026 | A | 54,000 | A | — | Aug 2, 2036 | Common Stock | 54,000 | 54,000 | D |
Explanation of responses
- F125% of the shares subject to the option shall vest and become exercisable on August 2, 2027, and the remaining shares shall vest in a series of 36 successive equal monthly installments measured from August 2, 2027, subject to the Reporting Person's Continuous Service (as defined in the Company's 2018 Plan) through each such applicable vesting date.
- F2The initial Form 3 filed on August 5, 2026 was erroneously filed. This Form 4 replaces the Form 3 filed.